Dr Lucio D’Anna is a Consultant Neurologist at the Department of Stroke & Neurosciences at Imperial College London NHS Trust. He is also Honorary Senior Lecturer at the Division of Brain Sciences, Imperial College London.
Parkinsonian Dementia Symptoms
People with PD dementia (PDD) may experience changes in memory, concentration and judgment; trouble interpreting visual information; visual hallucinations; delusions, especially paranoid ideas; depression, irritability and anxiety; and sleep disturbances, including excessive daytime drowsiness and rapid eye movement (REM) sleep disorder. Memory problems can occur even at the early stage of PD greatly affecting the quality of life. Similar cognitive impairment occurs in atypical Parkinsonism such as PSP, MSA and CBS. HD also causes a decline in thinking and reasoning skills, including memory, concentration, judgment and ability to plan and organize.
Parkinsonian Dementia Diagnosis
We use cutting-edge technology CANTAB to assess the severity of cognitive deficits in people with Parkinsonian dementia. This enables us to provide an early diagnosis of cognitive impairment and effectively manage it.
Risk Assessment & Prevention
As with most medical conditions, the sooner you know what is happening, the better. Dementech Neurosciences offers a wide range of cutting-edge services, specifically designed for people with Parkinsonian Dementia, such as the Dementech Biomarker Tools and genetic counselling appointments. By using the latest advances in imaging and genetics, we are able to answer all your questions regarding the diagnosis, prognosis, monitoring progression and response to treatment.
Parkinsonian Dementia Treatment
At Dementech Neurosciences, we offer a multidisciplinary approach to treat all the variety of symptoms of Parkinsonian Dementia. We have in-house speech and language therapist, occupational therapist, dietitian, psychologist and psychiatrist to manage effectively cognitive symptoms. Moreover, we offer the opportunity to participate in clinical trials testing novel pharmacological intervention, before they become available to the public, aiming to delay the progression of the disease. Caregivers may experience significant stresses and have a high level of burden; therefore we also offer caregiver support.